The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.20
Ask: 65.80
Change: 0.60 (0.93%)
Spread: 1.60 (2.492%)
Open: 64.00
High: 65.00
Low: 64.00
Prev. Close: 64.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adoption of New LTIP and Grant of Options

18 Oct 2023 07:00

RNS Number : 4459Q
IDOX PLC
18 October 2023

18 October 2023

Idox plc

('Idox' or the 'Group' or the 'Company')

Adoption of New LTIP and Grant of Options

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, announces that on 1 September 2023 it adopted a new long-term incentive plan ("LTIP"), with share option awards to be made to key members of Idox's management team including certain of its persons discharging managerial responsibilities ("PDMRs").

The new LTIP has been established following consultation with certain major shareholders of the Group and external advisors. Potential awards and performance criteria have been benchmarked against share incentive schemes for other AIM quoted companies.

The Group's Remuneration Committee (the "Committee") granted these awards on 17 October 2023, with an effective grant date of 1 November 2022 ("Grant Date"), to encourage long-term value creation for the Company's shareholders, and so that the individuals identified as key people to lead the business into the future are appropriately incentivised in a manner that aligns with the interests of the Group's stakeholders. The new LTIP will supersede the existing LTIP established in 2019.

Pursuant to the LTIP, the Company granted nil-cost options over the following ordinary shares:

- 1,711,213 ordinary shares to David Meaden

- 1,283,409 ordinary shares to Anoop Kang

- 1,344,524 ordinary shares to Jonathan Legdon

- 763,934 ordinary shares to Ruth Paterson

The share option awards under the LTIP will ordinarily vest three years after the Grant Date (the "Performance Period") subject to the grantee's continued service and achievement of the necessary performance criteria, and are exercisable for seven years thereafter.

The performance criteria that apply to the awards are set out below. Once the first threshold has been exceeded, options will vest on a straight-line basis between the target thresholds.

· The vesting of up to 50 per cent of the award is subject to the Company's absolute total shareholder return ("TSR") performance over the Performance Period.

Annual TSR growth rate

% of options vesting (of those subject to the TSR criteria)

5.0%

8.3%

10.0%

33.3%

17.3%

100.0%

· The vesting of up to 25 per cent of the award is subject to the achievement of adjusted diluted earnings per share ("EPS") growth over the Performance Period. The EPS for the base year ended 31 October 2022 was 2.44p.

Annual EPS growth rate

% of options vesting (of those subject to the EPS criteria)

4.5%

8.3%

8.05%

33.3%

12.0%

100.0%

· The vesting of up to 25 per cent of the award is subject to the Company's revenue performance over the Performance Period. Revenue for the base year ended 31 October 2022 was £66.2m.

Annual revenue growth rate

% of options vesting (of those subject to the Revenue criteria)

6.6%

8.3%

10.0%

33.3%

15.0%

100.0%

The Committee will review the performance conditions at periodic intervals to ensure they remain appropriate. As a result of any such review, the Committee will retain discretion to amend the conditions where appropriate having regard to overall Company performance and wider stakeholder experience.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. David Meaden

2. Anoop Kang

3. Jonathan Legdon

4. Ruth Paterson

2

Reason for the notification

a)

Position/status

1. CEO

2. CFO

3. COO

4. CLCO

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Idox plc

b)

LEI

213800Z3FE6PWVSUGE70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each ("Ordinary Shares")

GB0002998192

b)

Nature of the transaction

Conditional Grant of Nil Cost Share Options

c)

Price(s) and volume(s)

Price (s)

Volume(s)

1.

Nil

1,711,213

2.

Nil

1,283,409

3.

Nil

1,344,524

4.

nil

763,934

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

17 October 2023

f)

Place of the transaction

Outside a trading venue

-Ends-

Enquiries:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Anoop Kang, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Michael Burke

James Smith

MHP Group

+44 (0) 203 128 8276

Reg HoareOllie HoareMatthew Taylor

idox@mhpgroup.com

About Idox plc For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAPEXFSEDFFA
Date   Source Headline
14th Nov 20227:00 amRNSHolding(s) in Company
7th Oct 20222:42 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSAcquisition
26th Sep 20227:00 amRNSExercise of Share Options & Total Voting Rights
1st Aug 20227:00 amRNSTotal Voting Rights
15th Jul 20227:00 amRNSIdox awarded new contract for Idox Cloud
28th Jun 20227:00 amRNSIssue of Equity
15th Jun 20227:00 amRNSHalf-year Report
19th May 20227:00 amRNSFY22 H1 trading update
19th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSGrant of Options
28th Mar 20227:13 amRNSExercise of Share Options & Total Voting Rights
23rd Mar 20229:51 amRNSExercise of Share Options & Total Voting Rights
16th Mar 202211:22 amRNSResult of AGM & Board Change
16th Mar 20227:00 amRNSAGM Trading Update
21st Feb 20227:01 amRNSPosting of Annual Report and Notice of AGM
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.